EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Feasibility of amikacin antimicrobial intravenous regional limb perfusion in canine pelvic limbs

Gillian Davies, Samantha L Morello, Tatiana H Ferreira iD, Kyle J Bartholomew, Brett Nemke, Jason A Bleedorn iD

American Journal of Veterinary Research · 2025

DOI: 10.2460/ajvr.25.03.0098 ↗

Kurz gefasst

Fachartikel in der Zeitschrift American Journal of Veterinary Research, 2025. Verfasst von Gillian Davies und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Surgical Sciences, School of Veterinary Medicine, University of Wisconsin-Madison, Madison, WI. Hauptthemen laut MEDLINE: Amikacin, Anti-Bacterial Agents, Hindlimb. Die Arbeit nennt 40 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

To use contrast venography and intravascular pressure monitoring to determine optimal perfusion volumes during IV regional limb perfusion (IVRLP) and to determine systemic, articular, and osseous concentrations of amikacin achieved following IVRLP in dogs.

Methods

Animals were anesthetized and had lateral saphenous vein catheters placed. Incremental IV contrast venography with pressure monitoring was performed on one limb with a tourniquet proximal to the stifle to estimate vascular filling volume. Intravenous regional limb perfusion was performed on the contralateral hindlimb using 5 mg/kg amikacin, IV, diluted to the total filling volume. Systemic blood samples and synovial fluid were collected prior to infusion and immediately prior to and 30 minutes after tourniquet removal. Tibial bone marrow aspirates were collected after tourniquet removal. Samples were analyzed for amikacin concentration.

Results

Contrast IVRLP perfused the pelvic limb distal to the tourniquet with a median volume of 10 mL (range, 6 to 16 mL) and perfusion pressure of 77.5 mm Hg (range, 37 to 130 mm Hg). The median systemic amikacin concentration with the tourniquet in place was low (0.6 μg/mL) and increased to 11.5 μg/mL following removal. The amikacin concentrations in synovial fluid and bone marrow were 109.8 and 49.7 μg/mL, respectively, with high interdog variability.

Conclusions

Contrast venography and tissue amikacin levels suggest that IVRLP is feasible in the canine pelvic limb as the amikacin concentrations in 75% of synovial fluid and 33% of bone marrow samples exceeded 10 times the MIC required to inhibit 90% of isolates (MIC 90 ) reported for Staphylococcus pseudintermedius . Clinical Relevance This study offers a baseline protocol for canine IVRLP for use in limb infections. Further studies should focus on drug delivery optimization and clinical application.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AmikacinAnti-Bacterial AgentsHindlimbAnimalsDogsMaleFemaleSynovial FluidInfusions, IntravenousFeasibility StudiesPerfusion

Stichwörter der Autor:innen

amikacinantibiotic therapydoginfectionregional limb perfusion

Substanzen

AmikacinAnti-Bacterial Agents

Autor:innen und Institutionen

  • Department of Surgical Sciences, School of Veterinary Medicine, University of Wisconsin-Madison, Madison, WI.
  • Department of Clinical Sciences, Center for Veterinary Business and Entrepreneurship, College of Veterinary Medicine, Cornell University, Ithaca, NY.
  • Comparative Orthopedic Research Laboratory, School of Veterinary Medicine, University of Wisconsin-Madison, Madison, WI.
  • Department of Clinical Sciences, College of Veterinary Medicine and Biomedical Sciences, Colorado State University, Fort Collins, CO.

ORCID-Profile: Tatiana H Ferreira, Jason A Bleedorn

Zitieren

APA

Davies, G., Morello, S. L., Ferreira, T. H., Bartholomew, K. J., Nemke, B., & Bleedorn, J. A. (2025). Feasibility of amikacin antimicrobial intravenous regional limb perfusion in canine pelvic limbs. American Journal of Veterinary Research. https://doi.org/10.2460/ajvr.25.03.0098

Vancouver

Davies G, Morello SL, Ferreira TH, Bartholomew KJ, Nemke B, Bleedorn JA. Feasibility of amikacin antimicrobial intravenous regional limb perfusion in canine pelvic limbs. American Journal of Veterinary Research. 2025. doi:10.2460/ajvr.25.03.0098

BibTeX
@article{Davies2025,
  author = {Davies, Gillian and Morello, Samantha L and Ferreira, Tatiana H and Bartholomew, Kyle J and Nemke, Brett and Bleedorn, Jason A},
  title = {Feasibility of amikacin antimicrobial intravenous regional limb perfusion in canine pelvic limbs},
  journal = {American Journal of Veterinary Research},
  year = {2025},
  doi = {10.2460/ajvr.25.03.0098}
}
Kostenlos starten →